Valiant Organics posted FY26 operational revenue of Rs 739 crore with an EBITDA of Rs 101 crore, marking a financial recovery from previous losses. The company reported a net profit of Rs 34 crore, though shareholders should note that figures are affected by the divestment of Valiant Laboratories Limited in 2023, making year-on-year comparisons complex.
Valiant Organics Reports FY26 Financial Recovery
Operational Revenue: Rs 739 Crore | EBITDA Margin: 13.64%
Reader Takeaway: Strong recovery in profitability and margins, though investors must adjust for the recent Valiant Laboratories divestment.
What just happened
Valiant Organics released its FY26 performance metrics during its 21st Annual General Meeting. The company reported operational revenue of Rs 739 crore and an EBITDA of Rs 101 crore, representing an EBITDA margin of 13.64%. The company posted a profit after tax (PAT) of Rs 34 crore, signaling a turnaround from losses experienced in FY24 and FY25.
Why this matters
The company has demonstrated improved operational efficiency, with margins rising significantly from 8.59% in FY25. This growth is driven by its core chemistries—Hydrogenation (48% of revenue), Ammonolysis (26%), and Chlorination (20%)—serving the dyes, pigments, and agro-chemical sectors.
The backstory
The financial landscape for Valiant Organics shifted following the IPO of its material step-down subsidiary, Valiant Laboratories Limited (VLL). In October 2023, the company diluted its stake in VLL to 46.83%, resulting in VLL ceasing to be a consolidated subsidiary. Management has advised that this structural change impacts the comparability of consolidated financials against previous years.
Risks to watch
Investors should monitor potential raw material price volatility, as the company operates in a specialty chemical segment with high import dependence. Additionally, the change in the consolidation scope of VLL requires caution when performing historical trend analysis.
Context metrics
- Total Production Capacity: 80,000 TPA
- Net Debt to Equity: 0.33x
- Key End-User Exposure: Dyes & Pigments (45%), Agro Chemicals (24%), Pharmaceuticals (21%)
What to track next
Shareholders should track the sustainability of the 13.64% EBITDA margin and future capacity utilization across the company's six manufacturing plants, which utilize Zero Liquid Discharge technology.